COMPARATIVE BIOAVAILABILITY OF DIFFERENT PREPARATIONS OF PARACETAMOL ADMINISTERED IN SINGLE DOSES.WOJCICKI J; GAWRONSKA SZKLARZ B; KAZIMIERCZYK J et al.1977; ZBL. PHARM. PHARMAKOTHERAP. LAB.-DIAGNOST.; DTSCH.; DA. 1977; VOL. 116; NO 4; PP. 355-359; BIBL. 5 REF.Article

BIODISPONIBILITE DU N-ACETYL P AMINOPHENOLWOJCICKI J; GAWRONSKA SZKLARZ B; KAZIMIERCZYK J et al.1977; ROCZ. POMORSK. AKAD. MED. KAROLA SWIERCZEWSKIEGO SZCZECINIE; POLSKA; DA. 1977; VOL. 23; PP. 245-253; ABS. RUSSE ANGL.; BIBL. 1/2 P.Article

EFFECT OF UNILATERAL NEPHRECTOMY ON THE PHARMACOKINETICS OF ROLITETRACYCLINE IN RABBITSWOJCICKI J; GAWRONSKA SZKLARZ B; KARDEL MIZERSKA T et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 9; PP. 1456-1458; ABS. GER; BIBL. 9 REF.Article

Natural (-)- and unnatural (+)-enantiomers of morphine: comparative metabolism and effect of morphine and phenobarbital treatmentRANE, A; GAWRONSKA-SZKLARZ, B; SVENSSON, J.-O et al.The Journal of pharmacology and experimental therapeutics. 1985, Vol 234, Num 3, pp 761-765, issn 0022-3565Article

Association of cytokine gene polymorphisms and the release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasonePAWLIK, A; BASKIEWICZ-MASIUK, M; MACHALINSKI, B et al.International immunopharmacology. 2006, Vol 6, Num 3, pp 351-357, issn 1567-5769, 7 p.Article

Involvement of P-gp in the process of apoptosis in peripheral blood mononuclear cellsPAWLIK, A; BASKIEWICZ-MASIUK, M; MACHALINSKI, B et al.International immunopharmacology. 2005, Vol 5, Num 5, pp 821-828, issn 1567-5769, 8 p.Article

The influence of N-acetyl-transferase 2 polymorphism on rheumatoid arthritis activityPAWLIK, A; OSTANEK, L; BRZOSKO, I et al.Clinical and experimental rheumatology (Testo stampato). 2004, Vol 22, Num 1, pp 99-102, issn 0392-856X, 4 p.Article

Relationship between acetylation polymorphism and risk of atopic diseasesGAWRONSKA-SZKLARZ, B; LUSZAWSKA-KUTRZEBA, T; CZAJA-BULSA, G et al.Clinical pharmacology and therapeutics. 1999, Vol 65, Num 5, pp 562-569, issn 0009-9236Article

TNF-α: 308 promoter polymorphism in patients with rheumatoid arthritisPAWLIK, A; FLORCZAK, M; OSTANEK, L et al.Scandinavian journal of rheumatology. 2005, Vol 34, Num 1, pp 22-26, issn 0300-9742, 5 p.Article

IL1β+3953 exon 5 and IL-2 -330 promoter polymorphisms in patients with rheumatoid arthritisPAWLIK, A; KURZAWSKI, M; FLORCZAK, M et al.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 2, pp 159-164, issn 0392-856X, 6 p.Article

Il-6 promoter polymorphism in patients with rheumatoid arthritisPAWLIK, A; WRZESNIEWSKA, J; FLORCZAK, M et al.Scandinavian journal of rheumatology. 2005, Vol 34, Num 2, pp 109-113, issn 0300-9742, 5 p.Article

Effect of unilateral nephrectomy on the pharmacokinetics of amikacin in humansDROZDZIK, M; DOMANSKI, L; WOJCICKI, J et al.Journal of pharmacy and pharmacology. 2002, Vol 54, Num 4, pp 509-514, issn 0022-3573Article

The correlation between FcγRIIA polymorphism and renal allograft survivalPAWLIK, A; FLORCZAK, M; BAK, L et al.Transplantation proceedings. 2002, Vol 34, Num 8, pp 3138-3139, issn 0041-1345, 2 p.Article

Studies on the pharmacokinetics and pharmacodynamics of propranolol in hyperlipidemiaWOJCICKI, J; SULZYC-BIELICKA, V; KUTRZEBA, J et al.Journal of clinical pharmacology. 1999, Vol 39, Num 8, pp 826-833, issn 0091-2700Article

IL-2 and TNF-α promoter polymorphisms in patients with acute kidney graft rejectionPAWLIK, A; DOMANSKI, L; ROZANSKI, J et al.Transplantation proceedings. 2005, Vol 37, Num 5, pp 2041-2043, issn 0041-1345, 3 p.Article

CYP2D6 and GSTM1 genotypes in a Polish populationGAWRONSKA-SZKLARZ, B; WOJCICKI, M; KUPRIANOWICZ, A et al.European journal of clinical pharmacology. 1999, Vol 55, Num 5, pp 389-392, issn 0031-6970Article

Pharmacokinetics of propranolol and atenolol in patients after partial gastric resection: a comparative studyWOJCICKI, J; WOJCIENCHOWSKI, G; WOJCICKI, M et al.European journal of clinical pharmacology. 2000, Vol 56, Num 1, pp 75-79, issn 0031-6970Article

Effects of hypolipemic therapy on the pharmacokinetics of propranololWOJCICKI, J; STERNA, R; SULZYC-BIELICKA, V et al.Current therapeutic research. 1999, Vol 60, Num 1, pp 20-30, issn 0011-393XArticle

Pharmacokinetics of phenazone (antipyrine) in rabbits with experimental common bile duct obstructionWOJCICKI, J; SULIKOWSKI, T; WOJCICKI, M et al.British journal of pharmacology. 1996, Vol 117, Num 1, pp 1-4, issn 0007-1188Article

N-acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbancesGAWRONSKA-SZKLARZ, B; GORNIK, W; PAWLIK, A et al.European journal of clinical pharmacology. 1997, Vol 51, Num 6, pp 431-435, issn 0031-6970Article

The FcγRIIa polymorphism in patients with chronic kidney graft rejectionPAWLIK, A; FLORCZAK, M; BAK, L et al.Transplantation proceedings. 2004, Vol 36, Num 5, pp 1311-1313, issn 0041-1345, 3 p.Article

The expansion of CD4⁺CD28^- T cells in patients with chronic kidney graft rejectionPAWLIK, A; FLORCZAK, M; MASIUK, M et al.Transplantation proceedings. 2003, Vol 35, Num 8, pp 2902-2904, issn 0041-1345, 3 p.Article

Debrisoquine hydroxylation of a Polish populationKUNICKI, P. K; SITKIEWICZ, D; PAWLIK, A et al.European journal of clinical pharmacology. 1995, Vol 47, Num 6, pp 503-505, issn 0031-6970Article

Evaluation of the efficacy of a combined formulation (Grippostad®-C) in the therapy of symptoms of common cold: a randomized, double-blind, multicenter trialKOYTCHEV, R; VLAHOV, V; BACRATCHEVA, N et al.International journal of clinical pharmacology and therapeutics. 2003, Vol 41, Num 3, pp 114-125, issn 0946-1965, 12 p.Article

Pharmacokinetics of intragastrically administered digoxin in rabbits with experimental bile duct obstructionWOJCICKI, M; DROZDZIK, M; SULIKOWSKI, T et al.Journal of pharmacy and pharmacology. 1997, Vol 49, Num 11, pp 1082-1085, issn 0022-3573Article